FIA
NNVC icon

Foundations Investment Advisors’s NanoViricides NNVC Stock Holding History

Foundations Investment Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.13K Buy
10,005
+5
+0.1% +$5 ﹤0.01% 1158
2025
Q4 		$11.3K Hold
10,000
– – ﹤0.01% 1103
2025
Q3 		$14.3K Hold
10,000
– – ﹤0.01% 1039
2025
Q2 		$14K Buy
+10,000
New +$13.7K ﹤0.01% 914

Other funds holding NNVC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $91.3M AUM 21.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Foundations Investment Advisors's NNVC Position: Q1 2026 in Review

Foundations Investment Advisors increased its NanoViricides (NNVC) stake by 0.05% in Q1 2026, buying an estimated $5 and bringing the position to 10,005 shares worth $9.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Foundations Investment Advisors first reported a position in NNVC in Q2 2025 and has held it in 4 quarters since. The position peaked at $14.3K in Q3 2025. 48 funds tracked by Wall St. Rank hold NNVC as of Q1 2026.

  • Foundations Investment Advisors held 10,005 shares of NanoViricides worth $9.13K as of Q1 2026.
  • Foundations Investment Advisors bought 5 NanoViricides shares in Q1 2026, an estimated $5.
  • NanoViricides made up ﹤0.01% of Foundations Investment Advisors's portfolio in Q1 2026, its #1158 holding.
  • Foundations Investment Advisors first reported a position in NanoViricides in Q2 2025 and has held it in 4 quarters since.
  • Foundations Investment Advisors's NanoViricides position peaked at $14.3K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q1 2026.

Based on Foundations Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.